nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—SLC7A11—forelimb zeugopod—peripheral nervous system neoplasm	0.044	0.234	CbGeAlD
Acetylcysteine—GRIN1—ganglion—peripheral nervous system neoplasm	0.0133	0.0706	CbGeAlD
Acetylcysteine—GRIN2B—nerve—peripheral nervous system neoplasm	0.0128	0.0682	CbGeAlD
Acetylcysteine—GRIN2B—ganglion—peripheral nervous system neoplasm	0.0127	0.0673	CbGeAlD
Acetylcysteine—SLC7A11—tongue—peripheral nervous system neoplasm	0.0118	0.0629	CbGeAlD
Acetylcysteine—GRIN2A—nerve—peripheral nervous system neoplasm	0.0112	0.0596	CbGeAlD
Acetylcysteine—GRIN2A—ganglion—peripheral nervous system neoplasm	0.0111	0.0589	CbGeAlD
Acetylcysteine—GSS—ganglion—peripheral nervous system neoplasm	0.00968	0.0515	CbGeAlD
Acetylcysteine—GRIN2D—brainstem—peripheral nervous system neoplasm	0.00647	0.0344	CbGeAlD
Acetylcysteine—GRIN1—brainstem—peripheral nervous system neoplasm	0.00577	0.0307	CbGeAlD
Acetylcysteine—GRIN2B—brainstem—peripheral nervous system neoplasm	0.0055	0.0293	CbGeAlD
Acetylcysteine—GRIN2A—brainstem—peripheral nervous system neoplasm	0.00481	0.0256	CbGeAlD
Acetylcysteine—GSS—trigeminal ganglion—peripheral nervous system neoplasm	0.00475	0.0253	CbGeAlD
Acetylcysteine—ACY1—cerebellum—peripheral nervous system neoplasm	0.0045	0.024	CbGeAlD
Acetylcysteine—GSS—parotid gland—peripheral nervous system neoplasm	0.00448	0.0239	CbGeAlD
Acetylcysteine—GSS—brainstem—peripheral nervous system neoplasm	0.00421	0.0224	CbGeAlD
Acetylcysteine—GRIN2D—cerebellum—peripheral nervous system neoplasm	0.00319	0.017	CbGeAlD
Acetylcysteine—CHUK—cerebellum—peripheral nervous system neoplasm	0.00311	0.0165	CbGeAlD
Acetylcysteine—GRIN1—cerebellum—peripheral nervous system neoplasm	0.00284	0.0151	CbGeAlD
Acetylcysteine—GRIN2B—cerebellum—peripheral nervous system neoplasm	0.00271	0.0144	CbGeAlD
Acetylcysteine—SLC7A11—cerebellum—peripheral nervous system neoplasm	0.00256	0.0136	CbGeAlD
Acetylcysteine—GRIN2A—cerebellum—peripheral nervous system neoplasm	0.00237	0.0126	CbGeAlD
Acetylcysteine—IKBKB—cerebellum—peripheral nervous system neoplasm	0.00211	0.0112	CbGeAlD
Acetylcysteine—GSS—cerebellum—peripheral nervous system neoplasm	0.00207	0.011	CbGeAlD
Acetylcysteine—Thinking abnormal—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00258	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00123	0.00256	CcSEcCtD
Acetylcysteine—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00122	0.00255	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00122	0.00254	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00122	0.00254	CcSEcCtD
Acetylcysteine—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00122	0.00254	CcSEcCtD
Acetylcysteine—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00122	0.00254	CcSEcCtD
Acetylcysteine—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00252	CcSEcCtD
Acetylcysteine—Oedema—Melphalan—peripheral nervous system neoplasm	0.00121	0.00251	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00121	0.00251	CcSEcCtD
Acetylcysteine—Stomatitis—Cisplatin—peripheral nervous system neoplasm	0.00121	0.00251	CcSEcCtD
Acetylcysteine—Shock—Isotretinoin—peripheral nervous system neoplasm	0.0012	0.0025	CcSEcCtD
Acetylcysteine—Shock—Tretinoin—peripheral nervous system neoplasm	0.0012	0.0025	CcSEcCtD
Acetylcysteine—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.0012	0.00249	CcSEcCtD
Acetylcysteine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00119	0.00248	CcSEcCtD
Acetylcysteine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00119	0.00248	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00119	0.00248	CcSEcCtD
Acetylcysteine—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.00119	0.00247	CcSEcCtD
Acetylcysteine—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.00119	0.00247	CcSEcCtD
Acetylcysteine—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00246	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00118	0.00246	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00118	0.00246	CcSEcCtD
Acetylcysteine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00118	0.00245	CcSEcCtD
Acetylcysteine—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00117	0.00244	CcSEcCtD
Acetylcysteine—Cardiac disorder—Vincristine—peripheral nervous system neoplasm	0.00117	0.00242	CcSEcCtD
Acetylcysteine—Gait disturbance—Epirubicin—peripheral nervous system neoplasm	0.00116	0.00242	CcSEcCtD
Acetylcysteine—Thinking abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00239	CcSEcCtD
Acetylcysteine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00114	0.00237	CcSEcCtD
Acetylcysteine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.00237	CcSEcCtD
Acetylcysteine—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.00114	0.00237	CcSEcCtD
Acetylcysteine—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00236	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.00113	0.00235	CcSEcCtD
Acetylcysteine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00113	0.00234	CcSEcCtD
Acetylcysteine—Stomatitis—Etoposide—peripheral nervous system neoplasm	0.00111	0.0023	CcSEcCtD
Acetylcysteine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.0011	0.00228	CcSEcCtD
Acetylcysteine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00109	0.00227	CcSEcCtD
Acetylcysteine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00109	0.00227	CcSEcCtD
Acetylcysteine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00109	0.00226	CcSEcCtD
Acetylcysteine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00109	0.00226	CcSEcCtD
Acetylcysteine—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00108	0.00226	CcSEcCtD
Acetylcysteine—Gait disturbance—Doxorubicin—peripheral nervous system neoplasm	0.00108	0.00224	CcSEcCtD
Acetylcysteine—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00108	0.00224	CcSEcCtD
Acetylcysteine—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.00224	CcSEcCtD
Acetylcysteine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00108	0.00224	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00106	0.00221	CcSEcCtD
Acetylcysteine—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00106	0.00221	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00106	0.00219	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00106	0.00219	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00104	0.00217	CcSEcCtD
Acetylcysteine—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.00103	0.00214	CcSEcCtD
Acetylcysteine—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00103	0.00214	CcSEcCtD
Acetylcysteine—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00212	CcSEcCtD
Acetylcysteine—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.001	0.00209	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.001	0.00208	CcSEcCtD
Acetylcysteine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000999	0.00208	CcSEcCtD
Acetylcysteine—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000998	0.00207	CcSEcCtD
Acetylcysteine—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000991	0.00206	CcSEcCtD
Acetylcysteine—Mental disability—Epirubicin—peripheral nervous system neoplasm	0.000986	0.00205	CcSEcCtD
Acetylcysteine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000979	0.00204	CcSEcCtD
Acetylcysteine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000974	0.00203	CcSEcCtD
Acetylcysteine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000971	0.00202	CcSEcCtD
Acetylcysteine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000971	0.00202	CcSEcCtD
Acetylcysteine—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000967	0.00201	CcSEcCtD
Acetylcysteine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000966	0.00201	CcSEcCtD
Acetylcysteine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000966	0.00201	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00096	0.002	CcSEcCtD
Acetylcysteine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000959	0.00199	CcSEcCtD
Acetylcysteine—Flushing—Etoposide—peripheral nervous system neoplasm	0.000945	0.00196	CcSEcCtD
Acetylcysteine—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000945	0.00196	CcSEcCtD
Acetylcysteine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000926	0.00193	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000926	0.00193	CcSEcCtD
Acetylcysteine—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000924	0.00192	CcSEcCtD
Acetylcysteine—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000919	0.00191	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000917	0.00191	CcSEcCtD
Acetylcysteine—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.000914	0.0019	CcSEcCtD
Acetylcysteine—Mental disability—Doxorubicin—peripheral nervous system neoplasm	0.000912	0.0019	CcSEcCtD
Acetylcysteine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000911	0.0019	CcSEcCtD
Acetylcysteine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000908	0.00189	CcSEcCtD
Acetylcysteine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000904	0.00188	CcSEcCtD
Acetylcysteine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000901	0.00187	CcSEcCtD
Acetylcysteine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000901	0.00187	CcSEcCtD
Acetylcysteine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.0009	0.00187	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000896	0.00186	CcSEcCtD
Acetylcysteine—Oedema—Vincristine—peripheral nervous system neoplasm	0.000893	0.00186	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000893	0.00186	CcSEcCtD
Acetylcysteine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000889	0.00185	CcSEcCtD
Acetylcysteine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000872	0.00181	CcSEcCtD
Acetylcysteine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000866	0.0018	CcSEcCtD
Acetylcysteine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000865	0.0018	CcSEcCtD
Acetylcysteine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000865	0.0018	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000863	0.00179	CcSEcCtD
Acetylcysteine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000854	0.00177	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000852	0.00177	CcSEcCtD
Acetylcysteine—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.000845	0.00176	CcSEcCtD
Acetylcysteine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000834	0.00173	CcSEcCtD
Acetylcysteine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000826	0.00172	CcSEcCtD
Acetylcysteine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000824	0.00171	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000818	0.0017	CcSEcCtD
Acetylcysteine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000816	0.0017	CcSEcCtD
Acetylcysteine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000815	0.00169	CcSEcCtD
Acetylcysteine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000808	0.00168	CcSEcCtD
Acetylcysteine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000808	0.00168	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.0008	0.00166	CcSEcCtD
Acetylcysteine—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.000796	0.00166	CcSEcCtD
Acetylcysteine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00079	0.00164	CcSEcCtD
Acetylcysteine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000789	0.00164	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000789	0.00164	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000788	0.00164	CcSEcCtD
Acetylcysteine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000784	0.00163	CcSEcCtD
Acetylcysteine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000779	0.00162	CcSEcCtD
Acetylcysteine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000777	0.00162	CcSEcCtD
Acetylcysteine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000777	0.00162	CcSEcCtD
Acetylcysteine—Rash—Topotecan—peripheral nervous system neoplasm	0.000777	0.00162	CcSEcCtD
Acetylcysteine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000776	0.00161	CcSEcCtD
Acetylcysteine—Cough—Etoposide—peripheral nervous system neoplasm	0.000773	0.00161	CcSEcCtD
Acetylcysteine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000771	0.0016	CcSEcCtD
Acetylcysteine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000771	0.0016	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000771	0.0016	CcSEcCtD
Acetylcysteine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00077	0.0016	CcSEcCtD
Acetylcysteine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00077	0.0016	CcSEcCtD
Acetylcysteine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00077	0.0016	CcSEcCtD
Acetylcysteine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000767	0.0016	CcSEcCtD
Acetylcysteine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000767	0.00159	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000763	0.00159	CcSEcCtD
Acetylcysteine—Rash—Melphalan—peripheral nervous system neoplasm	0.000761	0.00158	CcSEcCtD
Acetylcysteine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00076	0.00158	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000749	0.00156	CcSEcCtD
Acetylcysteine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000738	0.00153	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000738	0.00153	CcSEcCtD
Acetylcysteine—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000737	0.00153	CcSEcCtD
Acetylcysteine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000736	0.00153	CcSEcCtD
Acetylcysteine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000736	0.00153	CcSEcCtD
Acetylcysteine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000732	0.00152	CcSEcCtD
Acetylcysteine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000732	0.00152	CcSEcCtD
Acetylcysteine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000726	0.00151	CcSEcCtD
Acetylcysteine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000726	0.00151	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000723	0.0015	CcSEcCtD
Acetylcysteine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000717	0.00149	CcSEcCtD
Acetylcysteine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000713	0.00148	CcSEcCtD
Acetylcysteine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000706	0.00147	CcSEcCtD
Acetylcysteine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000706	0.00147	CcSEcCtD
Acetylcysteine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000704	0.00146	CcSEcCtD
Acetylcysteine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000702	0.00146	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000699	0.00145	CcSEcCtD
Acetylcysteine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000683	0.00142	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000682	0.00142	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000682	0.00142	CcSEcCtD
Acetylcysteine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000676	0.0014	CcSEcCtD
Acetylcysteine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.00066	0.00137	CcSEcCtD
Acetylcysteine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000658	0.00137	CcSEcCtD
Acetylcysteine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000655	0.00136	CcSEcCtD
Acetylcysteine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000645	0.00134	CcSEcCtD
Acetylcysteine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000643	0.00134	CcSEcCtD
Acetylcysteine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000636	0.00132	CcSEcCtD
Acetylcysteine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000635	0.00132	CcSEcCtD
Acetylcysteine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00063	0.00131	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000624	0.0013	CcSEcCtD
Acetylcysteine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000624	0.0013	CcSEcCtD
Acetylcysteine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.00062	0.00129	CcSEcCtD
Acetylcysteine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000613	0.00127	CcSEcCtD
Acetylcysteine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000609	0.00127	CcSEcCtD
Acetylcysteine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000594	0.00123	CcSEcCtD
Acetylcysteine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00059	0.00123	CcSEcCtD
Acetylcysteine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000589	0.00122	CcSEcCtD
Acetylcysteine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000588	0.00122	CcSEcCtD
Acetylcysteine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000584	0.00121	CcSEcCtD
Acetylcysteine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000584	0.00121	CcSEcCtD
Acetylcysteine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000582	0.00121	CcSEcCtD
Acetylcysteine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000575	0.00119	CcSEcCtD
Acetylcysteine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000573	0.00119	CcSEcCtD
Acetylcysteine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000572	0.00119	CcSEcCtD
Acetylcysteine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000568	0.00118	CcSEcCtD
Acetylcysteine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000566	0.00118	CcSEcCtD
Acetylcysteine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000564	0.00117	CcSEcCtD
Acetylcysteine—Rash—Vincristine—peripheral nervous system neoplasm	0.000563	0.00117	CcSEcCtD
Acetylcysteine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000562	0.00117	CcSEcCtD
Acetylcysteine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00055	0.00114	CcSEcCtD
Acetylcysteine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000533	0.00111	CcSEcCtD
Acetylcysteine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00053	0.0011	CcSEcCtD
Acetylcysteine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00053	0.0011	CcSEcCtD
Acetylcysteine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.00053	0.0011	CcSEcCtD
Acetylcysteine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000524	0.00109	CcSEcCtD
Acetylcysteine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000518	0.00108	CcSEcCtD
Acetylcysteine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000515	0.00107	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000514	0.00107	CcSEcCtD
Acetylcysteine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000512	0.00106	CcSEcCtD
Acetylcysteine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000502	0.00104	CcSEcCtD
Acetylcysteine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000498	0.00103	CcSEcCtD
Acetylcysteine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000497	0.00103	CcSEcCtD
Acetylcysteine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000497	0.00103	CcSEcCtD
Acetylcysteine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00049	0.00102	CcSEcCtD
Acetylcysteine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00049	0.00102	CcSEcCtD
Acetylcysteine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000479	0.000996	CcSEcCtD
Acetylcysteine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000478	0.000994	CcSEcCtD
Acetylcysteine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.000991	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.000989	CcSEcCtD
Acetylcysteine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000469	0.000975	CcSEcCtD
Acetylcysteine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00046	0.000956	CcSEcCtD
Acetylcysteine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.000956	CcSEcCtD
Acetylcysteine—Rash—Etoposide—peripheral nervous system neoplasm	0.000456	0.000948	CcSEcCtD
Acetylcysteine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000456	0.000947	CcSEcCtD
Acetylcysteine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000445	0.000926	CcSEcCtD
Acetylcysteine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000437	0.000908	CcSEcCtD
Acetylcysteine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000901	CcSEcCtD
Acetylcysteine—Nausea—Etoposide—peripheral nervous system neoplasm	0.00043	0.000893	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00042	0.000873	CcSEcCtD
Acetylcysteine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000857	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000843	CcSEcCtD
Acetylcysteine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000843	CcSEcCtD
Acetylcysteine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.00084	CcSEcCtD
Acetylcysteine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.000834	CcSEcCtD
Acetylcysteine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000829	CcSEcCtD
Acetylcysteine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000396	0.000823	CcSEcCtD
Acetylcysteine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000394	0.000819	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000815	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000808	CcSEcCtD
Acetylcysteine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000788	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.00078	CcSEcCtD
Acetylcysteine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.00078	CcSEcCtD
Acetylcysteine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000767	CcSEcCtD
Acetylcysteine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.000761	CcSEcCtD
Acetylcysteine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000757	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000754	CcSEcCtD
Acetylcysteine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000751	CcSEcCtD
Acetylcysteine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00036	0.000749	CcSEcCtD
Acetylcysteine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000742	CcSEcCtD
Acetylcysteine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000729	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00035	0.000728	CcSEcCtD
Acetylcysteine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000695	CcSEcCtD
Acetylcysteine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.000693	CcSEcCtD
Acetylcysteine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000686	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000673	CcSEcCtD
Acetylcysteine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000322	0.00067	CcSEcCtD
Acetylcysteine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000666	CcSEcCtD
Acetylcysteine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000621	CcSEcCtD
Acetylcysteine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.00062	CcSEcCtD
Acetylcysteine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000616	CcSEcCtD
Acetylcysteine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000596	CcSEcCtD
Acetylcysteine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000575	CcSEcCtD
Acetylcysteine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000557	CcSEcCtD
Acetylcysteine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000552	CcSEcCtD
Acetylcysteine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000536	CcSEcCtD
Acetylcysteine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000531	CcSEcCtD
Acetylcysteine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000531	CcSEcCtD
Acetylcysteine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000516	CcSEcCtD
Acetylcysteine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000501	CcSEcCtD
Acetylcysteine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000496	CcSEcCtD
Acetylcysteine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000492	CcSEcCtD
Acetylcysteine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000491	CcSEcCtD
Acetylcysteine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000463	CcSEcCtD
Acetylcysteine—GRIN2B—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000213	0.000643	CbGpPWpGaD
Acetylcysteine—IKBKB—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	0.000212	0.000641	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—ERBB2—peripheral nervous system neoplasm	0.000212	0.000641	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—GNAS—peripheral nervous system neoplasm	0.00021	0.000636	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—PTPN11—peripheral nervous system neoplasm	0.00021	0.000634	CbGpPWpGaD
Acetylcysteine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—AKT1—peripheral nervous system neoplasm	0.00021	0.000634	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—NRAS—peripheral nervous system neoplasm	0.000209	0.000632	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IFNB1—peripheral nervous system neoplasm	0.000209	0.000632	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—MET—peripheral nervous system neoplasm	0.000208	0.000628	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000208	0.000627	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000207	0.000624	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—PTPN11—peripheral nervous system neoplasm	0.000207	0.000624	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	0.000206	0.000622	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—CASP3—peripheral nervous system neoplasm	0.000206	0.000621	CbGpPWpGaD
Acetylcysteine—GRIN1—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	0.000205	0.00062	CbGpPWpGaD
Acetylcysteine—GRIN2A—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000205	0.000619	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000205	0.000618	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000204	0.000616	CbGpPWpGaD
Acetylcysteine—CHUK—TCR Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000202	0.000611	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—ERBB2—peripheral nervous system neoplasm	0.000201	0.000607	CbGpPWpGaD
Acetylcysteine—GRIN2B—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	0.0002	0.000605	CbGpPWpGaD
Acetylcysteine—CHUK—TNF alpha Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000199	0.0006	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by Interleukins—HRAS—peripheral nervous system neoplasm	0.000198	0.000598	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000197	0.000596	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—NRAS—peripheral nervous system neoplasm	0.000197	0.000594	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—NRAS—peripheral nervous system neoplasm	0.000196	0.000591	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Receptor Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000196	0.000591	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—NRAS—peripheral nervous system neoplasm	0.000195	0.000588	CbGpPWpGaD
Acetylcysteine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—AKT1—peripheral nervous system neoplasm	0.000194	0.000585	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis—AKT1—peripheral nervous system neoplasm	0.000194	0.000585	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—NRAS—peripheral nervous system neoplasm	0.000194	0.000585	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000193	0.000582	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000192	0.000581	CbGpPWpGaD
Acetylcysteine—GRIN2D—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000191	0.000578	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—NRAS—peripheral nervous system neoplasm	0.000191	0.000577	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Receptor Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000191	0.000575	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—PTPN11—peripheral nervous system neoplasm	0.00019	0.000575	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IFNB1—peripheral nervous system neoplasm	0.00019	0.000573	CbGpPWpGaD
Acetylcysteine—CHUK—PI-3K cascade—AKT1—peripheral nervous system neoplasm	0.000189	0.000571	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000187	0.000566	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—PTPN11—peripheral nervous system neoplasm	0.000187	0.000566	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000187	0.000564	CbGpPWpGaD
Acetylcysteine—CHUK—PI3K/AKT activation—AKT1—peripheral nervous system neoplasm	0.000184	0.000557	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000183	0.000554	CbGpPWpGaD
Acetylcysteine—CHUK—GAB1 signalosome—AKT1—peripheral nervous system neoplasm	0.000183	0.000553	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000183	0.000553	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD34—peripheral nervous system neoplasm	0.000183	0.000551	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—NRAS—peripheral nervous system neoplasm	0.000182	0.000551	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—NRAS—peripheral nervous system neoplasm	0.000182	0.000551	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—NRAS—peripheral nervous system neoplasm	0.000182	0.000551	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—NRAS—peripheral nervous system neoplasm	0.000181	0.000546	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.00018	0.000544	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by Interleukins—HRAS—peripheral nervous system neoplasm	0.00018	0.000542	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—NRAS—peripheral nervous system neoplasm	0.000179	0.000541	CbGpPWpGaD
Acetylcysteine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—peripheral nervous system neoplasm	0.000179	0.00054	CbGpPWpGaD
Acetylcysteine—GRIN1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000179	0.00054	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—NRAS—peripheral nervous system neoplasm	0.000178	0.000538	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000176	0.000531	CbGpPWpGaD
Acetylcysteine—GRIN2B—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000174	0.000526	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NRAS—peripheral nervous system neoplasm	0.000173	0.000523	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Receptor Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000173	0.000522	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—NRAS—peripheral nervous system neoplasm	0.000172	0.00052	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00017	0.000513	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—NRAS—peripheral nervous system neoplasm	0.000169	0.000509	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000169	0.000509	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000166	0.000502	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000166	0.000501	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD34—peripheral nervous system neoplasm	0.000166	0.0005	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—NRAS—peripheral nervous system neoplasm	0.000165	0.000499	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	0.000163	0.000493	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	0.000163	0.000492	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000162	0.000491	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PPP3R1—peripheral nervous system neoplasm	0.000162	0.00049	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000162	0.000489	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—NRAS—peripheral nervous system neoplasm	0.000161	0.000488	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—MYC—peripheral nervous system neoplasm	0.000161	0.000485	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—HRAS—peripheral nervous system neoplasm	0.00016	0.000483	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.00016	0.000483	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000159	0.000481	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000158	0.000478	CbGpPWpGaD
Acetylcysteine—CHUK—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	0.000157	0.000475	CbGpPWpGaD
Acetylcysteine—GRIN2A—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000157	0.000474	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	0.000156	0.000472	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000156	0.000471	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000156	0.00047	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NCAM1—peripheral nervous system neoplasm	0.000155	0.000469	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—HRAS—peripheral nervous system neoplasm	0.000153	0.000462	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—NRAS—peripheral nervous system neoplasm	0.000153	0.000462	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000152	0.000459	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	0.000151	0.000455	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	0.00015	0.000454	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.00015	0.000454	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—CASP3—peripheral nervous system neoplasm	0.000148	0.000447	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	0.000148	0.000447	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000147	0.000445	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000147	0.000445	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—HRAS—peripheral nervous system neoplasm	0.000144	0.000434	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—HRAS—peripheral nervous system neoplasm	0.000143	0.000432	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—peripheral nervous system neoplasm	0.000143	0.000431	CbGpPWpGaD
Acetylcysteine—IKBKB—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	0.000143	0.000431	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—HRAS—peripheral nervous system neoplasm	0.000142	0.00043	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—HRAS—peripheral nervous system neoplasm	0.000142	0.000428	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—AKT1—peripheral nervous system neoplasm	0.000141	0.000427	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000141	0.000427	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NCAM1—peripheral nervous system neoplasm	0.000141	0.000425	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ENO2—peripheral nervous system neoplasm	0.000141	0.000424	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—peripheral nervous system neoplasm	0.00014	0.000422	CbGpPWpGaD
Acetylcysteine—CHUK—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	0.000139	0.000419	CbGpPWpGaD
Acetylcysteine—GRIN1—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000137	0.000414	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000137	0.000413	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—AKT1—peripheral nervous system neoplasm	0.000135	0.000408	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—CASP3—peripheral nervous system neoplasm	0.000134	0.000406	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000134	0.000405	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000134	0.000404	CbGpPWpGaD
Acetylcysteine—GRIN2B—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000134	0.000403	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—HRAS—peripheral nervous system neoplasm	0.000133	0.000403	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—HRAS—peripheral nervous system neoplasm	0.000133	0.000403	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—peripheral nervous system neoplasm	0.000133	0.000403	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	0.000133	0.000402	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—HRAS—peripheral nervous system neoplasm	0.000132	0.000399	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TP53—peripheral nervous system neoplasm	0.000132	0.000398	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000131	0.000396	CbGpPWpGaD
Acetylcysteine—IKBKB—Insulin Signaling—HRAS—peripheral nervous system neoplasm	0.000131	0.000396	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—HRAS—peripheral nervous system neoplasm	0.000131	0.000396	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—HRAS—peripheral nervous system neoplasm	0.00013	0.000394	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—peripheral nervous system neoplasm	0.00013	0.000391	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—TP53—peripheral nervous system neoplasm	0.000129	0.00039	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—AKT1—peripheral nervous system neoplasm	0.000127	0.000384	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—peripheral nervous system neoplasm	0.000127	0.000383	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—AKT1—peripheral nervous system neoplasm	0.000126	0.000382	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—NRAS—peripheral nervous system neoplasm	0.000126	0.000381	CbGpPWpGaD
Acetylcysteine—IKBKB—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	0.000126	0.00038	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—AKT1—peripheral nervous system neoplasm	0.000126	0.00038	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—AKT1—peripheral nervous system neoplasm	0.000125	0.000378	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—NRAS—peripheral nervous system neoplasm	0.000124	0.000375	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—HRAS—peripheral nervous system neoplasm	0.000123	0.000373	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000123	0.000373	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—peripheral nervous system neoplasm	0.000123	0.000373	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000123	0.000372	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IFNB1—peripheral nervous system neoplasm	0.000122	0.000368	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000122	0.000367	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—peripheral nervous system neoplasm	0.000121	0.000365	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000119	0.000358	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000118	0.000358	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	0.000118	0.000357	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.000118	0.000356	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—AKT1—peripheral nervous system neoplasm	0.000118	0.000356	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	0.000118	0.000356	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—AKT1—peripheral nervous system neoplasm	0.000118	0.000356	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	0.000117	0.000352	CbGpPWpGaD
Acetylcysteine—IKBKB—Insulin Signaling—AKT1—peripheral nervous system neoplasm	0.000116	0.00035	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	0.000116	0.000349	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000116	0.000349	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	0.000115	0.000348	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—NRAS—peripheral nervous system neoplasm	0.000115	0.000346	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000114	0.000343	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SLC2A1—peripheral nervous system neoplasm	0.000113	0.000342	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	0.000113	0.000342	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—NRAS—peripheral nervous system neoplasm	0.000113	0.00034	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—HRAS—peripheral nervous system neoplasm	0.000112	0.000338	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—peripheral nervous system neoplasm	0.000112	0.000338	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000112	0.000337	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000111	0.000336	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000111	0.000335	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IFNB1—peripheral nervous system neoplasm	0.00011	0.000334	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—AKT1—peripheral nervous system neoplasm	0.000109	0.000329	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000109	0.000329	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.000107	0.000323	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	0.000107	0.000322	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	0.000104	0.000315	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000103	0.000311	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	0.000103	0.00031	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—AKT1—peripheral nervous system neoplasm	9.89e-05	0.000299	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—AKT1—peripheral nervous system neoplasm	9.88e-05	0.000298	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	9.87e-05	0.000298	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HGF—peripheral nervous system neoplasm	9.4e-05	0.000284	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—ERBB2—peripheral nervous system neoplasm	9.31e-05	0.000281	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HRAS—peripheral nervous system neoplasm	9.24e-05	0.000279	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—HRAS—peripheral nervous system neoplasm	9.08e-05	0.000274	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	8.94e-05	0.00027	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—HRAS—peripheral nervous system neoplasm	8.67e-05	0.000262	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.53e-05	0.000258	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HGF—peripheral nervous system neoplasm	8.53e-05	0.000258	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—HRAS—peripheral nervous system neoplasm	8.46e-05	0.000255	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—ERBB2—peripheral nervous system neoplasm	8.44e-05	0.000255	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HRAS—peripheral nervous system neoplasm	8.38e-05	0.000253	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	8.34e-05	0.000252	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—HRAS—peripheral nervous system neoplasm	8.24e-05	0.000249	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	8.11e-05	0.000245	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—AKT1—peripheral nervous system neoplasm	8.02e-05	0.000242	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.96e-05	0.00024	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	7.84e-05	0.000237	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	7.74e-05	0.000234	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—AKT1—peripheral nervous system neoplasm	7.66e-05	0.000231	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—AKT1—peripheral nervous system neoplasm	7.47e-05	0.000225	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.3e-05	0.00022	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—AKT1—peripheral nervous system neoplasm	7.27e-05	0.00022	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—NRAS—peripheral nervous system neoplasm	7.08e-05	0.000214	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.96e-05	0.00021	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PTPN11—peripheral nervous system neoplasm	6.86e-05	0.000207	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	6.8e-05	0.000205	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KNG1—peripheral nervous system neoplasm	6.62e-05	0.0002	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—NRAS—peripheral nervous system neoplasm	6.42e-05	0.000194	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	6.4e-05	0.000193	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.38e-05	0.000193	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTPN11—peripheral nervous system neoplasm	6.33e-05	0.000191	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.31e-05	0.000191	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.28e-05	0.00019	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PTPN11—peripheral nervous system neoplasm	6.22e-05	0.000188	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	6.17e-05	0.000186	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.79e-05	0.000175	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—AKT1—peripheral nervous system neoplasm	5.68e-05	0.000172	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ERBB2—peripheral nervous system neoplasm	5.42e-05	0.000164	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HRAS—peripheral nervous system neoplasm	5.18e-05	0.000156	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ERBB2—peripheral nervous system neoplasm	5.01e-05	0.000151	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	4.98e-05	0.00015	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ERBB2—peripheral nervous system neoplasm	4.92e-05	0.000148	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HRAS—peripheral nervous system neoplasm	4.7e-05	0.000142	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—AKT1—peripheral nervous system neoplasm	4.58e-05	0.000138	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	4.51e-05	0.000136	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.44e-05	0.000134	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	4.39e-05	0.000133	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—AKT1—peripheral nervous system neoplasm	4.15e-05	0.000125	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NRAS—peripheral nervous system neoplasm	4.13e-05	0.000125	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.02e-05	0.000121	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	3.98e-05	0.00012	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NRAS—peripheral nervous system neoplasm	3.81e-05	0.000115	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NRAS—peripheral nervous system neoplasm	3.74e-05	0.000113	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MYC—peripheral nervous system neoplasm	3.55e-05	0.000107	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.51e-05	0.000106	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.18e-05	9.61e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.18e-05	9.6e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HRAS—peripheral nervous system neoplasm	3.02e-05	9.11e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.89e-05	8.71e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HRAS—peripheral nervous system neoplasm	2.79e-05	8.41e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HRAS—peripheral nervous system neoplasm	2.74e-05	8.26e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.67e-05	8.05e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AKT1—peripheral nervous system neoplasm	2.66e-05	8.05e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.48e-05	7.5e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT1—peripheral nervous system neoplasm	2.46e-05	7.43e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.42e-05	7.3e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT1—peripheral nervous system neoplasm	2.42e-05	7.3e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.25e-05	6.8e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.04e-05	6.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.95e-05	5.89e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.85e-05	5.59e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.77e-05	5.34e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	1.73e-05	5.22e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.72e-05	5.2e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.56e-05	4.72e-05	CbGpPWpGaD
